Prostate Cancer Prediction Using Convolutional Neural Networks

Cancer-related mortality in men is highest among men who suffer from prostate cancer. The lack of clarity and consistency of early symptoms often makes diagnosis a challenge in the later stages (stages III and IV). Existing diagnostic techniques face challenges such as subjectivity, variability between observers, and lengthy testing processes involving biomarkers, biopsies, and imaging tests. This paper introduces a novel convolutional neural network (CNN) algorithm for prostate cancer diagnosis and prediction to overcome these drawbacks. An additional dataset of histopathology images was used to train and validate the system before it was put through its learning phase. In the study, 95.12% of cancerously derived cells were identified correctly and 93.02% were identified correctly, a remarkable accuracy of 98.07%. As a result of this study, Various challenges associated with expert evaluations by humans were successfully addressed, including higher misclassification rates, interdependencies between observers, and lengthy analysis periods. Prostate cancer diagnosis and prognosis have been made much simpler and faster by this research. Moving forward, to optimize the effectiveness of our proposed method, future investigations should explore the latest developments and innovations in this field.